Literature DB >> 15951530

Probiotics and barrier function in colitis.

P Gionchetti1, K M Lammers, F Rizzello, M Campieri.   

Abstract

Probiotic administration may exert a protective effect in colitis by preventing mucosal barrier disruption and influencing the extent of mucosal injury.

Entities:  

Mesh：

Year:  2005        PMID： 15951530      PMCID： PMC1774611          DOI： 10.1136/gut.2004.060640

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  28 in total

Review 1.  Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins.

Authors:  Alessio Fasano; James P Nataro
Journal:  Adv Drug Deliv Rev       Date:  2004-04-19       Impact factor: 15.470

2.  Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria.

Authors:  M F Bernet; D Brassart; J R Neeser; A L Servin
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

3.  Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression.

Authors:  D R Mack; S Michail; S Wei; L McDougall; M A Hollingsworth
Journal:  Am J Physiol       Date:  1999-04

4.  Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.

Authors:  T Mimura; F Rizzello; U Helwig; G Poggioli; S Schreiber; I C Talbot; R J Nicholls; P Gionchetti; M Campieri; M A Kamm
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

5.  Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells.

Authors:  Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Paolo Gionchetti; Fernando Rizzello; Elisabetta Caramelli; Diego Matteuzzi; Massimo Campieri
Journal:  FEMS Immunol Med Microbiol       Date:  2003-09-22

6.  Modulation of human dendritic cell phenotype and function by probiotic bacteria.

Authors:  A L Hart; K Lammers; P Brigidi; B Vitali; F Rizzello; P Gionchetti; M Campieri; M A Kamm; S C Knight; A J Stagg
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

7.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Authors:  W Kruis; P Fric; J Pokrotnieks; M Lukás; B Fixa; M Kascák; M A Kamm; J Weismueller; C Beglinger; M Stolte; C Wolff; J Schulze
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

8.  DNA from probiotic bacteria modulates murine and human epithelial and immune function.

Authors:  Humberto Jijon; Jody Backer; Hugo Diaz; Helen Yeung; David Thiel; Conor McKaigney; Claudio De Simone; Karen Madsen
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

9.  The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat.

Authors:  R Fabia; A Ar'Rajab; M L Johansson; R Willén; R Andersson; G Molin; S Bengmark
Journal:  Scand J Gastroenterol       Date:  1993-02       Impact factor: 2.423

10.  Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis.

Authors:  H Schmitz; C Barmeyer; M Fromm; N Runkel; H D Foss; C J Bentzel; E O Riecken; J D Schulzke
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682
View more
  2 in total

Review 1.  Advances in therapeutic approaches to ulcerative colitis and Crohn's disease.

Authors:  Simon Travis
Journal:  Curr Gastroenterol Rep       Date:  2005-12

Review 2.  Importance of nutrition in inflammatory bowel disease.

Authors:  Alfredo José Lucendo; Livia Cristina De Rezende
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.